Fang et al. [13] (Fang, Zhu et al. 2018) found that a panel of PRL, CEA, and CYFRA21 biomarkers was more effective than the individual biomarkers alone, with a relatively high sensitivity and specificity for the diagnosis of NSCLC. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.